Welcome to LookChem.com Sign In|Join Free

CAS

  • or

60295-11-6

Post Buying Request

60295-11-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

60295-11-6 Usage

Description

Tert-butyl 2-cyclohexylidenehydrazinecarboxylate is a hydrazine derivative with the molecular formula C13H23N3O2. It features a tert-butyl group and a cyclohexylidene substituent attached to the hydrazinecarboxylate moiety, which endows it with a distinctive structure and reactivity. This chemical compound is widely recognized for its role as a versatile building block in the synthesis of complex molecules, making it a valuable asset in the field of organic chemistry.

Uses

Used in Pharmaceutical Industry:
Tert-butyl 2-cyclohexylidenehydrazinecarboxylate is utilized as an intermediate in organic synthesis for the production of various organic compounds. Its unique molecular structure and reactivity make it a valuable component in the development of pharmaceuticals, contributing to the creation of novel drugs and therapeutic agents.
Used in Agrochemical Industry:
Similarly, in the agrochemical industry, tert-butyl 2-cyclohexylidenehydrazinecarboxylate serves as a key intermediate in the synthesis of a range of organic compounds. Its application is instrumental in the development of new agrochemical products, such as pesticides and herbicides, that are designed to improve agricultural productivity and crop protection.
Used in Organic Synthesis:
Tert-butyl 2-cyclohexylidenehydrazinecarboxylate is employed as a versatile building block in organic synthesis. Its distinctive structure allows it to participate in various chemical reactions, facilitating the construction of complex molecular architectures that are essential in the synthesis of advanced organic compounds for a multitude of applications.

Check Digit Verification of cas no

The CAS Registry Mumber 60295-11-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,0,2,9 and 5 respectively; the second part has 2 digits, 1 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 60295-11:
(7*6)+(6*0)+(5*2)+(4*9)+(3*5)+(2*1)+(1*1)=106
106 % 10 = 6
So 60295-11-6 is a valid CAS Registry Number.

60295-11-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name tert-butyl N-(cyclohexylideneamino)carbamate

1.2 Other means of identification

Product number -
Other names tert-butyl 2-cyclohexylidenehydrazinecarboxylate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:60295-11-6 SDS

60295-11-6Relevant articles and documents

Development and scale up of a route to cyclohexylhydrazine dimethanesulfonate

Connolly, Terrence J.,Crittall, Andrew J.,Ebrahim, Alkarim S.,Ji, Guijun

, p. 526 - 529 (2000)

A mild, high-yielding synthesis of cyclohexylhydrazine dimethane-sulfonate has been developed that is suitable for further scale up. The process consists of three chemical steps: condensation of cyclohexanone with tert-butyl carbazate, reduction of the hy

INHIBITORS OF BRUTON'S TYROSINE KINASE

-

Paragraph 0417, (2014/06/23)

The invention provides novel poly-substituted 5-membered heterocyclic compounds represented by Formula (IV), or a pharmaceutically acceptable salt, solvate, metabolites, polymorph, ester, tautomer or prodrug thereof, and a composition comprising these compounds. The compounds provided can be used as selective irreversible bruton's tyrosine kinase (Btk) inhibitors and is further useful to treat inflammatory, auto immune diseases associated with aberrant B-cell proliferation such as RA (rheumatoid arthritis) and cancers. This invention also provided the preparation of a medicament using of Formula (IV), and methods of preventing or treating diseases associated with excessive Btk activity in mammals, especially humans. Formula (IV)

Catalytic hydrophosphorylation of alkyl- and acylhydrazones

Matveeva,Podrugina,Kolesnikova,Prisyazhnoi,Karateev,Zefirov

experimental part, p. 418 - 424 (2011/02/17)

N-Boc- and N-acylhydrazino phosphonates were obtained for the first time by hydrophos- phorylation of the appropriate hydrazones of aliphatic and aromatic aldehydes and heterocyclic and aliphatic ketones in the presence of [tetra(tert-butyl)phthalocyanine

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 60295-11-6